CRScube and Mednet Join Forces to Revolutionize eClinical Solutions Worldwide

CRScube Acquires Mednet to Enhance Global eClinical Capabilities

In a strategic move to bolster its presence in the North American market, CRScube has announced the acquisition of Mednet, a well-known name in the eClinical technology realm. This acquisition represents a significant step forward for CRScube as it looks to expand globally and tap into new opportunities within the rapidly evolving life sciences industry.

Uniting Strengths for Innovative Solutions

By combining the expertise of two leading vendors in the eClinical field, CRScube and Mednet aim to deliver innovative solutions that cater to the growing demands of clinical trials. Both companies have demonstrated a steadfast commitment to evolving health research methodologies, blending technology with a focus on care for the individuals involved in clinical studies. The newly formed entity will leverage the strengths of both organizations to provide a more comprehensive suite of solutions, addressing diverse needs ranging from electronic data capture (EDC) to clinical trial management systems.

CRScube has established itself as Korea's leading eClinical provider, having supported over 6,000 trials globally. Its user satisfaction ratings, recognized by G2.com, affirm its strong foothold in the market. On the other hand, Mednet, with over 24 years of experience, has demonstrated operational excellence within the American market, successfully aiding in over 100 FDA approvals through its robust EDC-centric platform.

The merger not only diversifies the product offerings of both companies but also enhances their service capacity, allowing them to address clinical trial needs in a more comprehensive manner. CRScube and Mednet's combined expertise in Software as a Service (SaaS) will reshape how clinical trials are designed, managed, and executed, heralding a new era of efficiency and effectiveness.

A Vision for Future Clinical Trials

As the leaders of both organizations expressed, this acquisition is much more than just a business transaction – it is about shaping the future of clinical trials. According to Stanley Kim, CEO of CRScube, "Bringing CRScube and Mednet together is an important milestone in our journey to transform clinical trials. We aim for research to be simpler, smarter, and more human, and this merger is about realizing that vision on a global scale."

Similarly, Rob Robertson, the CEO of Mednet, echoed this sentiment, emphasizing the partnership's potential to create greater impact for research sponsors, clinical research organizations (CROs), and ultimately, the patients who rely on successful clinical trials for life-saving treatments.

A Seamless Transition for Clients

In the upcoming months, CRScube and Mednet will work closely to align their operations while still providing seamless service to their existing clients. The transition is intended to be as smooth as possible, ensuring that ongoing projects and clinical trials remain unaffected.

With the merger, clients can anticipate an enhanced range of services that feature combined strengths from both companies, increasing the scalability of their operations and fortifying their positions in the healthcare technology landscape. Together, they will forge a path toward innovation that prioritizes speed, quality, and a connected approach to eClinical technology.

About CRScube and Mednet

CRScube is recognized as a global leader in eClinical solutions, dedicated to enhancing the accessibility and efficiency of clinical trials. With over 1,000 clients and 6,000 trials under its belt, CRScube's technology is integral in streamlining data capture processes while complying with international regulatory standards.

Mednet, on the other hand, has garnered a reputation for its EDC-centric platform tailored to support clinical research across various sizes and complexities. With a robust user base exceeding 84,000, Mednet has facilitated a plethora of clinical trial participants, proving its critical role in the life sciences sector.

Together, CRScube and Mednet are set to redefine the landscape of clinical trials, setting new standards for innovation, trust, and service that benefit all stakeholders in the industry.